129 related articles for article (PubMed ID: 32613842)
1. Exploring serum metabolic markers for the discrimination of ccRCC from renal angiomyolipoma by metabolomics.
Xiang M; Du F; Dai J; Chen L; Geng R; Huang H; Xie B
Biomark Med; 2020 Jun; 14(8):675-682. PubMed ID: 32613842
[No Abstract] [Full Text] [Related]
2. miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinoma.
Lou N; Ruan AM; Qiu B; Bao L; Xu YC; Zhao Y; Sun RL; Zhang ST; Xu GH; Ruan HL; Yuan CF; Han WW; Shi HC; Yang HM; Zhang XP
Urol Oncol; 2017 Jan; 35(1):36.e7-36.e14. PubMed ID: 27633984
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic utility of S100A1, GLUT-1 and Caveolin-1 in renal tumors with oncocytic features: a comparative study].
Zhang W; Wang K; Yu W; Liu Y; Chu J; Jiang Y; Li Y
Zhonghua Bing Li Xue Za Zhi; 2015 Nov; 44(11):767-71. PubMed ID: 26888385
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Footprinting of a Clear Cell Renal Cell Carcinoma in Vitro Model for Human Kidney Cancer Detection.
Knott ME; Manzi M; Zabalegui N; Salazar MO; Puricelli LI; Monge ME
J Proteome Res; 2018 Nov; 17(11):3877-3888. PubMed ID: 30260228
[TBL] [Abstract][Full Text] [Related]
5. Accurate quantification of urinary metabolites for predictive models manifest clinicopathology of renal cell carcinoma.
Sato T; Kawasaki Y; Maekawa M; Takasaki S; Shimada S; Morozumi K; Sato M; Kawamorita N; Yamashita S; Mitsuzuka K; Mano N; Ito A
Cancer Sci; 2020 Jul; 111(7):2570-2578. PubMed ID: 32350988
[TBL] [Abstract][Full Text] [Related]
6. Value of global metabolomics in association with diagnosis and clinicopathological factors of renal cell carcinoma.
Sato T; Kawasaki Y; Maekawa M; Takasaki S; Saigusa D; Ota H; Shimada S; Yamashita S; Mitsuzuka K; Yamaguchi H; Ito A; Kinoshita K; Koshiba S; Mano N; Arai Y
Int J Cancer; 2019 Jul; 145(2):484-493. PubMed ID: 30628065
[TBL] [Abstract][Full Text] [Related]
7. The predictive and prognostic values of serum amino acid levels for clear cell renal cell carcinoma.
Zhang F; Ma X; Li H; Guo G; Li P; Li H; Gu L; Li X; Chen L; Zhang X
Urol Oncol; 2017 Jun; 35(6):392-400. PubMed ID: 28188089
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Biexponential and Monoexponential Model of Diffusion-Weighted Imaging for Distinguishing between Common Renal Cell Carcinoma and Fat Poor Angiomyolipoma.
Ding Y; Zeng M; Rao S; Chen C; Fu C; Zhou J
Korean J Radiol; 2016; 17(6):853-863. PubMed ID: 27833401
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted magnetic resonance imaging in the differentiation of angiomyolipoma with minimal fat from clear cell renal cell carcinoma.
Tanaka H; Yoshida S; Fujii Y; Ishii C; Tanaka H; Koga F; Saito K; Masuda H; Kawakami S; Kihara K
Int J Urol; 2011 Oct; 18(10):727-30. PubMed ID: 21815937
[TBL] [Abstract][Full Text] [Related]
10. Identification of dysregulated serum miR-508-3p and miR-885-5p as potential diagnostic biomarkers of clear cell renal carcinoma.
Liu S; Deng X; Zhang J
Mol Med Rep; 2019 Dec; 20(6):5075-5083. PubMed ID: 31661117
[TBL] [Abstract][Full Text] [Related]
11. Whole-Tumor Quantitative Apparent Diffusion Coefficient Histogram and Texture Analysis to Differentiation of Minimal Fat Angiomyolipoma from Clear Cell Renal Cell Carcinoma.
Li H; Li A; Zhu H; Hu Y; Li J; Xia L; Hu D; Kamel IR; Li Z
Acad Radiol; 2019 May; 26(5):632-639. PubMed ID: 30087067
[TBL] [Abstract][Full Text] [Related]
12. Circularity Index on Contrast-Enhanced Computed Tomography Helps Distinguish Fat-Poor Angiomyolipoma from Renal Cell Carcinoma: Retrospective Analyses of Histologically Proven 257 Small Renal Tumors Less Than 4 cm.
Kang HS; Park JJ
Korean J Radiol; 2021 May; 22(5):735-741. PubMed ID: 33660463
[TBL] [Abstract][Full Text] [Related]
13. CD10+ and CK7/RON- immunophenotype distinguishes renal cell carcinoma, conventional type with eosinophilic morphology from its mimickers.
Yasir S; Herrera L; Gomez-Fernandez C; Reis IM; Umar S; Leveillee R; Kava B; Jorda M
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):454-61. PubMed ID: 22417859
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of renal angiomyolipoma without visible fat from small clear cell renal cell carcinoma by using specific region of interest on contrast-enhanced CT: a new combination of quantitative tools.
Wang X; Song G; Jiang H
Cancer Imaging; 2021 Jul; 21(1):47. PubMed ID: 34225784
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G
Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793
[TBL] [Abstract][Full Text] [Related]
16. Increased level of serum leucine-rich-alpha-2-glycoprotein 1 in patients with clear cell renal cell carcinoma.
Nakanishi S; Goya M; Suda T; Yonamine T; Sugawa A; Saito S
BMC Urol; 2024 Apr; 24(1):94. PubMed ID: 38658967
[TBL] [Abstract][Full Text] [Related]
17. Monoexponential, biexponential, and stretched exponential diffusion-weighted imaging models: Quantitative biomarkers for differentiating renal clear cell carcinoma and minimal fat angiomyolipoma.
Li H; Liang L; Li A; Hu Y; Hu D; Li Z; Kamel IR
J Magn Reson Imaging; 2017 Jul; 46(1):240-247. PubMed ID: 27859853
[TBL] [Abstract][Full Text] [Related]
18. Rapidly Progressing Malignant Epithelioid Renal Angiomyolipoma: A Case Report.
Cho SW; Choi HJ; Lee S
Urol J; 2016 Apr; 13(2):2653-5. PubMed ID: 27085568
[No Abstract] [Full Text] [Related]
19. MDCT-based scoring system for differentiating angiomyolipoma with minimal fat from renal cell carcinoma.
Kim MH; Lee J; Cho G; Cho KS; Kim J; Kim JK
Acta Radiol; 2013 Dec; 54(10):1201-9. PubMed ID: 23864062
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma.
Yang J; Yang J; Gao Y; Zhao L; Liu L; Qin Y; Wang X; Song T; Huang C
PLoS One; 2014; 9(11):e111364. PubMed ID: 25368985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
